Kaletra (Lopinavir/Ritonavir): Research
- Lexiva + Kaletra -- Still a Bad Idea (March/April 2004)
A short review of a study presented at CROI 2004.
In Positively Aware, from Test Positive Aware Network
- Dosing Agenerase + Kaletra -- Trying to Juggle, Walk and Chew Gum All at the Same Time (March/April 2004)
A study presented at CROI 2004 bolsters support for the use of therapeutic drug monitoring to customize dosing.
In Positively Aware, from Test Positive Aware Network
- Drug Monitoring, NRTI Activity Help Predict Lopinavir/Ritonavir Response in Experienced Patients (February 11, 2004)
In The 11th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Nelfinavir, Lopinavir/Ritonavir Appear Safe for Hepatitis C Patients (February 10, 2004)
In The 11th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Boosted Atazanavir Similar to Boosted Lopinavir in Treatment-Experienced Patients (February 9, 2004)
In The 11th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Unboosted Atazanavir Better on Insulin Sensitivity Compared to Lopinavir/Ritonavir (February 9, 2004)
In The 11th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Once-Daily Lopinavir/Ritonavir as Effective as Twice-Daily, but Greater Side Effects Are Concern (February 9, 2004)
In The 11th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- HIV Drug Kaletra Proves Effective in Five-Year Study (September 16, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
On TheBodyPRO.com
- Kaletra "Monotherapy" Safe and Efficacious for Treatment-Naive Patients (September 15, 2003)
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from TheBodyPRO.com
- Treatment Regimens Containing Efavirenz, Nevirapine or Kaletra Are the Most Potent Options for Patients Starting Therapy (September 15, 2003)
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from TheBodyPRO.com
- 908 vs. Kaletra: Comparable for Experienced Patients, Not for Naive (July 28, 2003)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Kaletra: Could Upping the Dose Overcome Resistance? (July 18, 2003)
A 67 percent increase in the lopinavir/ritonavir dose was found to be far more effective than increasing only the ritonavir.
From aidsmap.com
- Pharmacokinetic-Pharmacodynamic Analysis of Lopinavir-Ritonavir in Combination With Efavirenz and Two Nucleoside Reverse Transcriptase Inhibitors in Extensively Pretreated Human Immunodeficiency Virus-Infected Patients (January 2003)
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- Research From the 42nd ICAAC: High Lopinavir Levels Predict High Lipids (December 2002)
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- Decreased Plasma Concentrations of Amprenavir and Lopinavir in HIV Patients on This Combination (July 8, 2002)
In The XIV International AIDS Conference, from TheBodyPRO.com
- Antiretroviral Update: Lopinavir/Ritonavir (Kaletra) (November 2001)
In HEPP News, from Brown Medical School
- Lack of Clinically Relevant Drug-Drug Interactions Between Tenofovir DF and Efavirenz, Indinavir, Lamivudine and Lopinavir/Ritonavir in Healthy Subjects (October 29, 2001)
In 8th European Conference on Clinical Aspects and Treatment of HIV-Infection, from TheBodyPRO.com
- Efficacy of Lopinavir in Heavily Pretreated Patients (October 27, 2001)
In 39th Annual Meeting of the Infectious Diseases Society of America, from TheBodyPRO.com
- A New Side Effect From Kaletra? (May 25, 2001)
From Canadian AIDS Treatment Information Exchange
On TheBodyPRO.com
- FDA Issues Pancreatitis Warning for New Drug Lopinavir (March 2001)
In WISE Words, from Project Inform
- Kaletra: Abbott Joins the Bandwagon (Spring 2001)
Recap of Kaletra's Phase III trial results and expanded access program.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
|
Advertisement
|
Email
Glossary
